Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
23 hedge funds and large institutions have $659K invested in Guardion Health Sciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 22 → 23 (+1)
1% more capital invested
Capital invested by funds: $654K → $659K (+$4.72K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$68.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.6K |
| 3 |
Renaissance Technologies
New York
|
+$22.7K |
| 4 |
E
Ergoteles
New York
|
+$21K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$120K |
| 2 |
VF
Virtu Financial
New York
|
-$5.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.28K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5K |
| 5 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$4K |
GHSI Hedge Fund Activity: Q3 2022 in Review
23 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2022, worth a combined $659K — up 0.72% from $654K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GHSI positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $68.8K. The largest seller was Vanguard Group, cutting an estimated $120K.
- 23 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2022, up from 22 in Q2 2022.
- Funds reported $659K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2022, up 0.72% quarter-over-quarter.
- 3 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2022 was Millennium Management, an estimated $68.8K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $120K sold.
Based on aggregated 13F filings for Q3 2022.